About Vance Kershner
Form D filings for Tangen Biosciences in 2023 list Vance Kershner as director.
Vance Kershner first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Vance Kershner in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Vance Kershner works with at each company, as listed on that company's latest Form D.
Tangen Biosciences, Inc. · Form D, Jun 6, 2023
AL
Alan Levin
Director
RP
Richard Birkmeyer, PhD
President and CEO, director
DW
Daniel Wagner
Director
CM
Christopher McLeod
Director
JD
John Davidson
Executive officer and director